- Home
- AUPH vs MFIC Comparison
AUPH vs MFIC Comparison
Compare AUPH & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- MFIC
- Stock Information
- Founded
- AUPH 1993
- MFIC 2004
- Country
- AUPH Canada
- MFIC United States
- Employees
- AUPH N/A
- MFIC N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- MFIC Finance/Investors Services
- Sector
- AUPH Health Care
- MFIC Finance
- Exchange
- AUPH Nasdaq
- MFIC Nasdaq
- Market Cap
- AUPH 1.3B
- MFIC 1.3B
- IPO Year
- AUPH 1999
- MFIC 2004
- Fundamental
- Price
- AUPH $9.50
- MFIC $13.58
- Analyst Decision
- AUPH Strong Buy
- MFIC Buy
- Analyst Count
- AUPH 3
- MFIC 8
- Target Price
- AUPH $10.33
- MFIC $14.50
- AVG Volume (30 Days)
- AUPH 1.5M
- MFIC 367.8K
- Earning Date
- AUPH 11-07-2024
- MFIC 11-07-2024
- Dividend Yield
- AUPH N/A
- MFIC 11.28%
- EPS Growth
- AUPH N/A
- MFIC 14.94
- EPS
- AUPH N/A
- MFIC 1.53
- Revenue
- AUPH $220,361,000.00
- MFIC $291,576,000.00
- Revenue This Year
- AUPH $36.97
- MFIC $12.92
- Revenue Next Year
- AUPH $16.43
- MFIC $17.11
- P/E Ratio
- AUPH N/A
- MFIC $8.82
- Revenue Growth
- AUPH 38.72
- MFIC 8.84
- 52 Week Low
- AUPH $4.71
- MFIC $12.26
- 52 Week High
- AUPH $10.67
- MFIC $16.36
- Technical
- Relative Strength Index (RSI)
- AUPH 58.10
- MFIC 41.51
- Support Level
- AUPH $9.22
- MFIC $13.37
- Resistance Level
- AUPH $9.76
- MFIC $14.28
- Average True Range (ATR)
- AUPH 0.42
- MFIC 0.16
- MACD
- AUPH -0.02
- MFIC -0.08
- Stochastic Oscillator
- AUPH 36.73
- MFIC 17.58
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.